unapproved-indication
1 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 20-1572 | Ramon D. Johnson, II v. Novartis Pharmaceuticals Corporation, et al. | Fifth Circuit | 2021-05-13 | Denied | Response WaivedRelisted (2) | brand-name-liability brand-name-manufacturer FDA-approval generic-drug generic-drug-liability label-defect leave-to-amend preemption product-liability state-law-claims texas-presumption-of-no-liability unapproved-indication | Whether a brand name drug manufacturer can be held liable for the defective label of a generic drug product |